Bowel Management Systems Market Worth 2.07 Billion USD By 2023

Summary

• Expanding Target Patient Population.
• Rapidly Growing Geriatric Population.
• Availability of Technologically Advanced Bowel Management Products.
• Favorable Reimbursement Scenario in Developed Countries.

Bowel Management Systems Market Dynamics:

Driver: Favorable reimbursement scenario in developed countries

The developed countries are reported to have favorable reimbursement scenarios for bowel management products, owing to which the demand for these products is expected to grow positively during the study period.

Restraint: Patient preference for non-invasive clinical management of FI

Currently, FI can be managed invasively (surgically) or non-invasively. Standard modes of surgical treatment include the injection of biomaterials into the anal canal, radiofrequency treatment of the anal canal, surgical repair of anal muscle injuries, sacral nerve stimulation, artificial bowel sphincter, muscle transposition to reinforce the anal sphincter, and the creation of a stoma. These often require long-term patient rehabilitation and maybe highly inconvenient and even severely painful.

As a result, the preference has grown for non-invasive approaches, such as the use of disposable products, medications, dietary and lifestyle changes, exercise, biofeedback, bowel training, transanal irrigation, antegrade colonic irrigation, and electrical stimulation. Additionally, these treatment alternatives are considered by surgeons as the first line of treatment as well. The significant adoption and patient preference for non-invasive treatment alternatives are expected to hamper the optimal growth of the bowel management systems market during the forecast period.

Download PDF Brochure@ Bowel Management Systems Market

What the Market Looks Like?

The global bowel management systems market is projected to reach USD 2.07 billion by 2023 from USD 1.74 billion in 2018, at a CAGR of 3.5% during the forecast period.

Recent Developments in Global Market:

# In 2018, Coloplast acquired IncoCare, a provider of continence products. This acquisition helped Coloplast expand its presence in Germany.

# In 2018, Axonics received marketing approval for its Axonics Sacral Neuromodulation System in Australia

# In 2018, Coloplast expanded its product portfolio by introducing a new product, SenSura Mio Concave, into its SenSura Mio product line.

# In 2016, ConvaTec entered into an agreement with Vizient, Inc. According to this agreement, members of Vizient get access to ConvaTec’s stoma care, bowel management, and patient skincare products.

# In 2016, A German court affirmed ConvaTec’s patent protection on Flexi-Seal Fecal Management System and ordered the competitor to cease from placing its product (infringing patent) in the market, as well as to recall its product already sent to market and to compensate ConvaTec.

Critical questions the report answers:

# Where will all these developments take the bowel management systems market in the long term?

# What are the upcoming trends for the bowel management systems market? Which segment in the bowel management market provides the most opportunity for growth?

# Who are the leading vendors operating in the market? What are the opportunities for new market entrants in the bowel management market?

Request Sample Pages@ Bowel Management Systems Market